ArticleJournal for immunotherapy of cancer2023

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.

Krisztian Homicsko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.